Applications Published 20 March 2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Stable benzimidazole formulation
Lahav, Raffael 1187599*
Method for enhancing stable cellular creatine concentration
Fortress Systems 1187600*
Novel preparation and administration form comprising an acid-labile active compound
Byk Gulden Lomberg Chemische Fabrik 1187601*
Injectable sustained release pharmaceutical compsn and processes for preparing same
Peptron 1187602*
Combination therapy for effecting weight loss and treating obesity
Najarian, Thomas 1187603*
Compounds and methods for the treatment of post-traumatic stress disorder
Berlant, Jeffrey 1187604*
Non-malignant disease treatment with RAS antagonists
Thyreos Corp; Ramot University Authority for Applied Research and Industrial Development 1187605*
Pharmaceutical compsn containing sibutramine and orlistat
Knoll 1187606*
Indole compounds
SmithKline Beecham 1187607*
Indole compounds
SmithKline Beecham 1187608*
Treatment and analysis of proliferative disorders
The General Hospital Corp 1187609*
Use of ion channel modulating agents
Neurosearch 1187610*
Ophthalmic histamine compsns and uses thereof
Maxim Pharmaceuticals 1187611*
Use of riluzole for the treatment of multiple sclerosis
Verneniging voor Christelijk Wetenschappelik Onderwijs 1187612*
Amide-substituted imidazoquinolines
3M Innovative Properties 1187613*
Substituted piperadines as melanocortin-4 receptor agonists
Merck 1187614*
Immunosuppressive effects of pteridine derivatives
KU Leuven Research & Development 1187615*
Thrombin inhibitors
Merck 1187616*
Topical ophthalmic mast cell stabilisers for treating allergic eye diseases
Alcon Laboratories 1187617*
Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
The General Hospital Corp 1187618*
Anti-tumour agents containing boroproline compounds
Point Therapeutics 1187619*
Antisense modulation of B7 protein expression
Isis Pharmaceuticals 1187620*
Novel pharmaceutical combination based on erythromycin and a carboxylic acid having 7 to 13 carbon atoms
Societe B F B 1187621*
Conformationally constrained backbone cyclised interleukin-6 antagonists
Peptor 1187624*
Structure-based design of compounds that inhibit detrimental cytotoxic T lymphocyte responses
Philadelphia Health and Education Corp 1187625*
Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischaemic or reperfused brain
Bionebraska 1187628*
Adjuvant compsns comprising saponin and a immunostimulatory oligonucleotide
SmithKline Beecham 1187629*
Rapid immunoassay to detect antibodies in saliva to diease-related microrganisms antigens
The Government of the United States of America as represented by the Secretary of the Navy 1187630*
Prevention of type-1 diabetes and other non-polio enterovirus diseases
Hyoety, Heikki; Knip, Mikael 1187631*
Treatment with anti-ERBB2 antibodies
Genentech 1187632*
Anaesthetic formulation comprising an NMDA-antagonist and an alpha-2 adrenergic agonist
Imperial College of Science, Technology and Medicine 1187635*
Injectable hyaluronate-sulphated polysaccharide conjugates
Orquest 1187636*
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
Deirx Pharmaceutical Corp 1187639*